Intrinsic Value of S&P & Nasdaq Contact Us

Pacira BioSciences, Inc. PCRX NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
45/100
0/7 Pass
SharesGrow Intrinsic Value
$12.11
-49%
Analyst Price Target
$27.00
+13.7%

Stock Statistics — PCRX

Pacira BioSciences, Inc. (PCRX) has a market capitalization of $1.02B and trades at $23.75. The 52-week range is 18.8-27.64.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 148.4, Earnings Per Share (EPS) of $0.16, annual revenue of $726.41M.

The stock has a beta of 0.20, operates in the Healthcare sector.

Trading Data
Current Price$23.75
52-Week Range18.8-27.64
Volume289.76K
Avg Volume (30D)834.42K
Market Cap$1.02B
Beta (1Y)0.20
Company
IPO Date2011-02-03
Employees788
CEOFrank D. Lee
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS6951271005
CUSIP695127100
Income (Latest Year)
Revenue$726.41M
Gross Profit$519.37M
EBITDA$119.13M
Operating Income$28.1M
Net Income$7.03M
EPS$0.16
EPS Diluted$0.16
Shares Outstanding$44.57M
Balance Sheet (Latest Year)
Total Assets$1.26B
Current Assets$547.97M
Cash & ST Investments$238.42M
Total Liabilities$571.81M
Total Debt$454.38M
Net Debt$295.84M
Total Equity$693.11M
Debt / Equity0.66
Valuation Ratios
P/E Ratio148.4
P/S Ratio1.41
P/B Ratio1.47
EV/EBITDA (approx)8.6
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message